News
-
-
COMMUNIQUÉ DE PRESSE
Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences
Andera Partners' portfolio company JenaValve Technology acquired by Edwards Lifesciences, marking a significant milestone in cardiovascular innovation with FDA approval expected by late 2025 -
-
-
COMMUNIQUÉ DE PRESSE
Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upcoming Clinical Milestones
Andera Partners' portfolio company TRiCares secures $50 million in Series D Financing to support upcoming clinical milestones for its tricuspid heart valve replacement system, Topaz -
-
-
-
-